NovoCure Limited is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of innovative therapy. NovoCure?s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma (GBM) and malignant pleural mesothelioma (MPM). NovoCure has ongoing or completed clinical trials investigating Tumor Treating Fields (TTFields) in brain metastases, non-small cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and liver cancer.